PSMA Expression in Renal Tumors
| Tissue | Tumor cells* (%) | Tumor vascular endothelium* (%) | Imaging |
| Clear cell RCC | 5/349 (1%) (8,15,16,51–54) | 259/310 (84%) (8,51–54) | 111In-7E11-C5.3 (61); 68Ga-HBED-CC (56,59,60,62,63,83); 18F-DCFPyL (57,65,84) |
| Papillary RCC | 5/109 (5%) (15,16,51–53) | 16/57 (28%) (51–53) | 68Ga-HBED-CC (59,63) |
| Chromophobe RCC | 0/57 (0%) (15,16,51–53) | 23/38 (61%) (51–53) | 68Ga-HBED-CC (59,60) |
| Oncocytoma | 0/47 (0%) (16,51–53) | 26/45 (58%) (51–53) | |
| Angiomyolipoma | 0/21 (0%) (8,52) | 4/20 (20%) (8,52) |
↵* Data are percentage of samples with stained cells or vasculature in relation to total number of pooled samples.